Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00786032 · ClinicalTrials.gov registry record

A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients

A clinical trial, sponsored by US Department of Veterans Affairs.

Completed
Registry status
27
Enrollment target

NCT00786032: Completed study, sponsored by US Department of Veterans Affairs.

NCT00786032 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00786032 has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
27 participants
Enrollment target

Study Summary

The goal of this VA demonstration project is to show that the Brain-computer interface (BCI) technology is a clinically practical and important new communication and control option that can improve the lives of veterans with amyotrophic lateral sclerosis (ALS). The project will test four well-supported hypotheses: (1) that people with ALS who find (or will soon find) conventional assistive technology inadequate can and will use a BCI system for important purposes in their daily lives without close technical oversight, 2) they will continue and even increase this use throughout the period of the study, (3) that BCI use will improve their lives, and 4) BCI will improve the lives of their families and caregivers.

Primary Outcome

This study will look at the 14 independent users usage of the BCI system. The continued use will be assessed by total time.

Interventions

  • DEVICE BCI Device

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2011-09
Est. Completion 2014-08
US Department of Veterans Affairs

632 total trials

What the finished NCT00786032 record still lists

NCT00786032 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which BCI Device is the first listed.

NCT00786032 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00786032 about?

NCT00786032 is a clinical study titled "A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients". The goal of this VA demonstration project is to show that the Brain-computer interface (BCI) technology is a clinically practical and important new communication and control option that can improve the lives of veterans with amyotrophic lateral sclerosis (ALS). The project will test four well-suppor...

What is the current status of trial NCT00786032?

This trial is currently completed. The enrollment target is 27 participants. The study started on 2011-09. Estimated completion is 2014-08.

What interventions are being tested in trial NCT00786032?

The interventions under investigation include: BCI Device (DEVICE).

Who is sponsoring clinical trial NCT00786032?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00786032, the US trial registry maintained by the National Library of Medicine. NCT00786032 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.